Search clinical trials for: In stent restenosis

Total 457579 results

Cook Group Incorporated

Completed

The ELUTES Clinical Trial (ELUTES I)

Coronary Artery Disease

United States
Cook Group Incorporated

Completed

In Stent ELUTES Study (ELUTES II)

Coronary Artery Disease

United States
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Australia, New Zealand, Germany
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (ISAR-TEST-5)

Coronary Heart Disease

Germany
University of Campania "Luigi Vanvitelli"

Completed

Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis

Restenosis | Tight Glycemic Control

Italy
Assistance Publique - Hôpitaux de Paris
Volcano Corporation

Completed

FROST 4: Study of the Optimal Spreading of a Coronary Stent Guided With Pressure Into the Coronary Arteries

Coronary Artery Insufficiency

France
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Gilard, Martine
Abbott Medical Devices; Clinical Research Organization and study management

Unknown

Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel (ITALICplus)

Restenosis

France
Azienda Ospedaliero Universitaria Maggiore della...

Completed

Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis

Myocardial Infarction | Restenosis

Italy
Abbott Medical Devices

Completed

ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation (ABSORB A)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Denmark, Poland, Netherlands
Tampere University
Boston Scientific Corporation

Completed

Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis (NIVUS)

Restenosis | Stent Thrombosis

Norway, Sweden, Denmark, Finland, Latvia
Cordis Corporation
Conor Medsystems

Completed

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Coronary Disease

United States
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Medtronic Vascular

Completed

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial (ENDEAVOR III)

Coronary Artery Disease
Fundación Médica para la Investigación y Desarrollo...
Abbott Medical Devices; Hospital San Carlos, Madrid; B.Braun Surgical SA

Unknown

RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent) (RIBS IV)

In-stent Restenosis

Spain
Eurocor GmbH

Completed

The Valentines Trial

Instent Restenosis

Netherlands, Italy, Germany
Korea University Anam Hospital
Korea University Guro Hospital; Yonsei University; Kyungpook National University... and other collaborators

Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial ) (Restenosis)

In-stent Arterial Restenosis

Korea, Republic of
Klinikum Coburg

Unknown

Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter

In-Stent Restenosis

Germany
The Hospital District of Satakunta

Unknown

Comparison of Bio-Active-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome (BASE-ACS)

Acute Coronary Syndrome

Finland
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
Abbott Medical Devices

Completed

Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteries (ZoMaxx™ I)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

New Zealand, Australia, Germany, France, Switzerland, Netherlands, United Kingdom, Portugal, Belgium, Denmark
Rambam Health Care Campus

Completed

In-stent Restenosis in Patients With Patent Previous Bare Metal Stent

In-stent Coronary Artery Restenosis

Israel
Medical University of Warsaw
KCRI

Unknown

Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA) (ISRII)

In-Stent Restenosis

Poland
Deutsches Herzzentrum Muenchen

Completed

Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents (DESIRE-2)

Coronary Artery Disease

Germany
Medical University of Vienna

Unknown

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial) (PACUBA 1)

Peripheral Arterial Disease

Austria
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
Ospedale San Donato

Terminated

A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR) (COMPACT-ISR)

Stable Angina | Unstable Angina

Italy
Rigshospitalet, Denmark

Unknown

Stenting With or Without Coating Compared With Angioplasty in Non-benestent Disease

Coronary Artery Disease

Denmark
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stents to Treat De Novo Coronary Lesions

Coronary Stenosis

United States
Boston Scientific Corporation

Completed

Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis (TAXUS V ISR)

Coronary Restenosis

United States, Canada
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Ospedale della Misericordia

Unknown

To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)

Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous Coronary

Italy
University Hospital, Saarland
B. Braun Melsungen AG

Completed

P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses

In-Stent Restenosis

Germany
Vulnerable Plaque Society

Completed

Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial (SINGLEKISS)

Ischemic Heart Disease | Restenosis

Japan
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Centro de estudios en Cardiologia Intervencionista
Eucatech AG

Completed

A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent (EUCATAX)

Coronary Artery Disease

Argentina
Abbott Medical Devices

Completed

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

United States, Switzerland, Netherlands, Spain, France, Sweden, Poland, Germany, Belgium, Denmark, Italy, United Kingdom
Abbott Medical Devices

Completed

ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries

Peripheral Vascular Diseases

Italy, Germany, Austria, France, Belgium, Greece, Spain
International Biomedical Systems S.p.A.

Unknown

European Multicenter, Randomized, Comparative Efficacy/Safety Study of the Mar-Tyn TiN-Coated Stent (MARTIN)

Coronary Artery Disease | Angioplasty, Transluminal, Percutaneous Coronary | Stents

Germany, Italy, Netherlands, Switzerland
Cordis Corporation

Completed

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial (DESSERT)

Coronary Artery Disease

Italy
Cordis Corporation

Completed

Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)

In-Stent Restenosis

United States
Rigshospitalet, Denmark

Unknown

Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction

Coronary Artery Disease

Denmark
Liuhuaqiao Hospital

Unknown

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

Drug Eluting Stent

China
International Biomedical Systems S.p.A.
CSC Pharmaceuticals

Unknown

Numen Stent Assessment Using OCT Technique in a Single Center Study (NAUTIC)

Hyperplasia | Restenosis

Austria
Deutsches Herzzentrum Muenchen

Completed

Oral Sirolimus for In-Stent Restenosis (OSIRIS)

Coronary Restenosis

Germany
Queen Elizabeth II Health Sciences Centre
Nova Scotia Health Research Foundation

Completed

Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic Patients (PPAR-G)

Coronary Artery Disease | Type 2 Diabetes Mellitus | Angina Pectoris | Percutaneous Coronary Intervention

Canada
Medical University of Vienna

Completed

Austrian Multivessel Taxus-Stent Registry (AUTAX)

Coronary Artery Disease

Austria
University of Rome Tor Vergata

Unknown

PIoglitazone for PrEvention of Restenosis in Diabetic Patients

Diabetes | Coronary Atherosclerosis | Coronary Restenosis

Italy
Deutsches Herzzentrum Muenchen

Completed

The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis (ISAR-TEST-2)

Coronary Disease

Germany
Sarepta Therapeutics, Inc.

Terminated

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

Coronary Artery Disease | Coronary Stent Restenosis

Search clinical trials for: In stent restenosis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations